VKVictoria Kulesh

Victoria Kulesh

*This is an algorithmically generated author record based on publicly available information.

Victoria Kulesh has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • SimuRg: Building, Fitting and Evaluating PK/PD Modeles

    by Victor Sokolov, Yaroslav Ugolkov, Anatoly Pokladyuk, Alina Melnikova, Victoria Kulesh

    Provides a unified workflow for building, fitting using external engines, and evaluating ordinary differential equation (ODE)-based pharmacokinetic/pharmacodynamic (PK/PD) models. Supports generation of estimation scenarios and control files for external engines (e.g., 'Monolix'), simulation of models using 'rxode2', and creation of goodness-of-fit diagnostics. Includes tools for covariate modeling, virtual population design, and local and global sensitivity analyses.

  • Open Access

    A tutorial for model‐based evaluation and translation of cardiovascular safety in preclinical trials

    by Victoria Kulesh, Igor Vasyutin, Alina Volkova, Kirill Peskov, Holly Kimko, Victor Sokolov, Ravindra Alluri

    Assessment of drug‐induced effects on the cardiovascular (CV) system remains a critical component of the drug discovery process enabling refinement of the therapeutic index. Predicting potential drug‐related unintended CV effects in the preclinical stage is necessary for first‐in‐human dose selection and preclusion of adverse CV effects in the clinical stage. According to the current guidelines for small molecules, nonclinical CV safety assessment conducted via telemetry analyses should be included in the safety pharmacology core battery studies. However, the manual for quantitative evaluation of the CV safety signals in animals is available only for electrocardiogram parameters (i.e., QT interval assessment), not for hemodynamic parameters (i.e., heart rate, blood pressure, etc.). Various model‐based approaches, including empirical pharmacokinetic‐toxicodynamic analyses and systems pharmacology modeling could be used in the framework of telemetry data evaluation. In this tutorial, we provide a comprehensive workflow for the analysis of nonclinical CV safety on hemodynamic parameters with a sequential approach, highlight the challenges associated with the data, and propose respective solutions, complemented with a reproducible example. The work is aimed at helping researchers conduct model‐based analyses of the CV safety in animals with subsequent translation of the effect to humans seamlessly and efficiently.